Calpain-Mediated Tau Cleavage: A Mechanism Leading to Neurodegeneration Shared by Multiple Tauopathies

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · see citing works

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.76.9.4350 · Cited by 51,421 · see citing works

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676 · see citing works

Assay of proteins in the presence of interfering materials

Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,191 · see citing works

The Calpain System

Goll, D. E., Thompson, V. F., Li, H., WEI, W., & Cong, J. (2003) · Physiological Reviews · doi:10.1152/physrev.00029.2002 · Cited by 2,826 · see citing works

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492 · see citing works

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · see citing works

Growth of a rat neuroblastoma cell line in serum-free supplemented medium.

Bottenstein, J. E., & SATO, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,282 · see citing works

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,462 · see citing works

[18] Quantification of β-sheet amyloid fibril structures with thioflavin T

LeVine, H. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09020-5 · Cited by 1,365 · see citing works

Neurotoxicity induces cleavage of p35 to p25 by calpain

Lee, M.-S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., & Tsai, L. (2000) · Nature · doi:10.1038/35012636 · Cited by 1,057 · see citing works

Calcium dyshomeostasis and intracellular signalling in alzheimer's disease

LaFerla, F. M. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn960 · Cited by 970 · see citing works

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · see citing works

MARK, a Novel Family of Protein Kinases That Phosphorylate Microtubule-Associated Proteins and Trigger Microtubule Disruption

Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E.-M., & Mandelkow, E. (1997) · Cell · doi:10.1016/s0092-8674(00)80208-1 · Cited by 878 · see citing works

Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease

Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831 · see citing works

Tau is essential to β-amyloid-induced neurotoxicity

Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807 · see citing works

Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding

Biernat, J., Gustke, N., Drewes, G., Mandelkow, E., & Mandelkow, E. (1993) · Neuron · doi:10.1016/0896-6273(93)90279-z · Cited by 796 · see citing works

Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase

Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., & Anderton, B. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90774-2 · Cited by 737 · see citing works

β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding

Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595 · see citing works

Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration.

Saito, K., Elce, J. S., Hamos, J. E., & Nixon, R. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2628 · Cited by 579 · see citing works

Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state.

Drewes, G., Lichtenberg‐Kraag, B., Döring, F., Mandelkow, E. M., Biernat, J., Goris, J., Dorée, M., & Mandelkow, E. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05272.x · Cited by 565 · see citing works

Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau

Mandelkow, E.-M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J. R., & Mandelkow, E. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81496-9 · Cited by 515 · see citing works

The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region.

Biernat, J., Mandelkow, E. M., Schröter, C., Lichtenberg‐Kraag, B., Steiner, B., Berling, B., Meyer, H., Mercken, M., Vandermeeren, A., & Goedert, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05204.x · Cited by 484 · see citing works

Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5

Baumann, K., Mandelkow, E., Biernat, J., Piwnica-Worms, H. M., & Mandelkow, E. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80849-p · Cited by 479 · see citing works

Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.

Takashima, A., Noguchi, K., Sato, K., Hoshino, T., & Imahori, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7789 · Cited by 381 · see citing works

Active Caspase-6 and Caspase-6-Cleaved Tau in Neuropil Threads, Neuritic Plaques, and Neurofibrillary Tangles of Alzheimer's Disease

Guo, H., Albrecht, S., Bourdeau, M., Petzke, T., Bergeron, C., & LeBlanc, A. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63317-2 · Cited by 287 · see citing works

p42 map kinase phosphorylation sites in microtubule‐associated protein tau are dephosphorylated by protein phosphatase 2A₁ Implications for Alzheimer's disease

Goedert, M., Cohen, E. S., Jakes, R., & Cohen, P. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81418-l · Cited by 272 · see citing works

Epidermal Growth Factor Activates m-Calpain (Calpain II), at Least in Part, by Extracellular Signal-Regulated Kinase-Mediated Phosphorylation

Glading, A., Bodnar, R. J., Reynolds, I. J., Shiraha, H., Satish, L., Potter, D. A., Blair, H. C., & Wells, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2499-2512.2004 · Cited by 271 · see citing works

The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced Neurodegeneration

Park, S.-Y., & Ferreira, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1125-05.2005 · Cited by 262 · see citing works

β-Amyloid-induced Dynamin 1 Degradation Is Mediated by N-Methyl-D-Aspartate Receptors in Hippocampal Neurons

Kelly, B. L., & Ferreira, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605081200 · Cited by 240 · see citing works

Developmental Changes in τ Phosphorylation: Fetal τ Is Transiently Phosphorylated in a Manner Similar to Paired Helical Filament‐τ Characteristic of Alzheimer's Disease

Brion, J., Smith, C. J., Couck, A., Gallo, J., & Anderton, B. H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07444.x · Cited by 202 · see citing works

Calpain in the CNS: From Synaptic Function to Neurotoxicity

Liu, J., Liu, M. C., & Wang, K. (2008) · Science Signaling · doi:10.1126/stke.114re1 · Cited by 198 · see citing works

Spectrin and calpain: a ‘target’ and a ‘sniper’ in the pathology of neuronal cells

Czogalla, A., & Sikorski, A. F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5097-0 · Cited by 194 · see citing works

Selective Phosphorylation of Adult Tau Isoforms in Mature Hippocampal Neurons Exposed to Fibrillar Aβ

Ferreira, A., Lu, Q., Orecchio, L., & Kosik, K. S. (1997) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1997.0615 · Cited by 178 · see citing works

Triggers of Full-Length Tau Aggregation: A Role for Partially Folded Intermediates

Chirita, C. N., Congdon, E. E., Yin, H., & Kuret, J. (2005) · Biochemistry · doi:10.1021/bi0500123 · Cited by 166 · see citing works

Tau and transgenic animal models

Götz, J. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00055-8 · Cited by 162 · see citing works

Site-Specific Nitration and Oxidative Dityrosine Bridging of the τ Protein by Peroxynitrite: Implications for Alzheimer's Disease

Reynolds, M. R., Berry, R. W., & Binder, L. I. (2005) · Biochemistry · doi:10.1021/bi047982v · Cited by 149 · see citing works

PD98059 Prevents Neurite Degeneration Induced by Fibrillar β‐Amyloid in Mature Hippocampal Neurons

Rapoport, M., & Ferreira, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740125.x · Cited by 139 · see citing works

Ligand-Dependent Tau Filament Formation: Implications for Alzheimer's Disease Progression

King, M. E., Ahuja, V., Binder, L. I., & Kuret, J. (1999) · Biochemistry · doi:10.1021/bi9911839 · Cited by 136 · see citing works

Brain-Derived Neurotrophic Factor and Epidermal Growth Factor Activate Neuronal m-Calpain via Mitogen-Activated Protein Kinase-Dependent Phosphorylation

Zadran, S., Jourdi, H., Rostamiani, K., Qin, Q., Bi, X., & Baudry, M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5120-09.2010 · Cited by 127 · see citing works

Glycogen Synthase Kinase 3β Induces Caspase-cleaved Tau Aggregation in Situ

Cho, J., & Johnson, G. V. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403364200 · Cited by 116 · see citing works

Tau Polymerization: Role of the Amino Terminus

Gamblin, T. C., Berry, R. W., & Binder, L. I. (2003) · Biochemistry · doi:10.1021/bi0272510 · Cited by 116 · see citing works

Calpain‐Induced Proteolysis of Normal Human Tau and Tau Associated with Paired Helical Filaments

Yang, L., & Ksiezak‐Reding, H. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.009_1.x · Cited by 113 · see citing works

Marked Calpastatin (CAST) Depletion in Alzheimer's Disease Accelerates Cytoskeleton Disruption and Neurodegeneration: Neuroprotection by CAST Overexpression

Rao, M. V., Mohan, P. S., Peterhoff, C. M., Yang, D., Schmidt, S., Stavrides, P. H., Campbell, J., Chen, Y., Jiang, Y., Paskevich, P. A., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4119-08.2008 · Cited by 107 · see citing works

Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment

Garg, S., Timm, T., Mandelkow, E.-M., Mandelkow, E., & Wang, Y. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.008 · Cited by 103 · see citing works

Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2

Adamec, E., Mohan, P. S., Vonsattel, J. P., & Nixon, R. A. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0528-6 · Cited by 100 · see citing works

Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons

Park, S.-Y., Tournell, C. E., Sinjoanu, R. C., & Ferreira, A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.012 · Cited by 91 · see citing works

N-Terminal Fragments of Tau Inhibit Full-Length Tau Polymerization in Vitro

Horowitz, P. M., LaPointe, N. E., Guillozet-Bongaarts, A. L., Berry, R. W., & Binder, L. I. (2006) · Biochemistry · doi:10.1021/bi061325g · Cited by 84 · see citing works

Deficiency in mRNA splicing in a cytochrome c mutant of neurospora crassa: importance of carboxy terminus for import of apocytochrome c into mitochondria.

Stuart, R. A., Neupert, W., & Tropschug, M. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02480.x · Cited by 80 · see citing works

A Complex Mechanism for Inducer Mediated Tau Polymerization

Carlson, S. W., Branden, M., Voss, K., Sun, Q., Rankin, C. A., & Gamblin, T. C. (2007) · Biochemistry · doi:10.1021/bi700403a · Cited by 73 · see citing works

Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation

Furukawa, K., Wang, Y., Yao, P. J., Fu, W., Mattson, M. P., Itoyama, Y., Onodera, H., D’Souza, I., Poorkaj, P., Bird, T. D., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02020.x · Cited by 70 · see citing works

Calcium-Regulated Signaling Pathways: Role in Amyloid β-Induced Synaptic Dysfunction

Xie, C.-W. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:6:1:053 · Cited by 64 · see citing works

A Luminol/Iodophenol Chemiluminescent Detection System for Western Immunoblots

Yakunin, A. F., & Hallenbeck, P. C. (1998) · Analytical Biochemistry · doi:10.1006/abio.1998.2571 · Cited by 60 · see citing works

Characteristics of the binding of thioflavin S to tau paired helical filaments

Santa‐María, I., Pérez, M., Hernández, F., Ávila, J., & Moreno, F. J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9307 · Cited by 53 · see citing works

Mitochondrial dysfunction in progressive supranuclear palsy

Albers, D. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00126-7 · Cited by 51 · see citing works

Peroxynitrite-Mediated τ Modifications Stabilize Preformed Filaments and Destabilize Microtubules through Distinct Mechanisms

Reynolds, M. R., Lukas, T. J., Berry, R. W., & Binder, L. I. (2006) · Biochemistry · doi:10.1021/bi052142h · Cited by 50 · see citing works

Regulation of Calpain-2 in Neurons: Implications for Synaptic Plasticity

Zadran, S., Bi, X., & Baudry, M. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8145-1 · Cited by 49 · see citing works

The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons

Sinjoanu, R. C., Kleinschmidt, S., Bitner, R. S., Brioni, J. D., Möller, A., & Ferreira, A. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.06.003 · Cited by 45 · see citing works

Neuroprotective and neurorescuing effects of isoform‐specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta‐amyloid toxicity

Law, A., Gauthier, S. G., & Quirion, R. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704179 · Cited by 43 · see citing works

Tau Protein in Familial and Sporadic Diseases

Yancopoulou, D., & Spillantini, M. G. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:37 · Cited by 40 · see citing works

Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease

Vaisid, T., Kosower, N. S., Katzav, A., Chapman, J., & Barnoy, S. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.004 · Cited by 40 · see citing works

Tau Released from Paired Helical Filaments with Formic Acid or Guanidine Is Susceptible to Calpain‐Mediated Proteolysis

Yang, L., Gordon‐Krajcer, W., & Ksiȩżak-Reding, H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041548.x · Cited by 24 · see citing works

Membrane Cholesterol Modulates β-Amyloid-dependent Tau Cleavage by Inducing Changes in the Membrane Content and Localization of N-Methyl-d-aspartic Acid Receptors

Nicholson, A. M., Methner, D. N. R., & Ferreira, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154138 · Cited by 15 · see citing works

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works

Roles of tau protein in health and disease

Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003 · see citing works

The importance of tau phosphorylation for neurodegenerative diseases

Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00083 · Cited by 475 · see citing works

Tau association with synaptic vesicles causes presynaptic dysfunction

Zhou, L., McInnes, J., Wierda, K., Holt, M., Herrmann, A. G., Jackson, R. J., Wang, Y.-C., Swerts, J., Beyens, J., Miskiewicz, K., et al. (2017) · Nature Communications · doi:10.1038/ncomms15295 · Cited by 434 · see citing works

Tau immunotherapy for Alzheimer's disease

Pedersen, J. T., & Sigurdsson, E. M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.03.003 · Cited by 247 · see citing works

Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers

Quinn, J. P., Corbett, N. J., Kellett, K. A. B., & Hooper, N. M. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-170959 · Cited by 170 · see citing works

Degradation of tau protein by autophagy and proteasomal pathways

Wang, Y., & Mandelkow, E. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120071 · Cited by 166 · see citing works

Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease

Vingtdeux, V., Sergeant, N., & Buée, L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00229 · Cited by 116 · see citing works

Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer’s Disease-Like Pathology and Cognitive Impairments

Mahaman, Y. A. R., Huang, F., Wu, M., Wang, Y., Wei, Z., Bao, J., Salissou, M. T. M., Ke, D., Wang, Q., Liu, R., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180091 · Cited by 93 · see citing works

The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties

Matsumoto, S.-E., Motoi, Y., Ishiguro, K., Tabira, T., Kametani, F., Hasegawa, M., & Hattori, N. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv351 · Cited by 66 · see citing works

Neuronal degeneration, synaptic defects, and behavioral abnormalities in tau45-230 transgenic mice

Lang, A. E., Riherd Methner, D. N., & Ferreira, A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.017 · Cited by 35 · see citing works

C/EBPβ/AEP Signaling Drives Alzheimer’s Disease Pathogenesis

Xiong, J., Zhang, Z., & Ye, K. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01025-w · Cited by 37 · see citing works

Short-term exposure to dim light at night disrupts rhythmic behaviors and causes neurodegeneration in fly models of tauopathy and Alzheimer's disease

Kim, M., Subramanian, M., Cho, Y.-H., Kim, G.-H., Lee, E., & Park, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.021 · Cited by 51 · see citing works

A Genomic Screen for Modifiers of Tauopathy Identifies Puromycin-Sensitive Aminopeptidase as an Inhibitor of Tau-Induced Neurodegeneration

Karsten, S. L., Sang, T.-K., Gehman, L. T., Chatterjee, S., Liu, J., Lawless, G. M., Sengupta, S., Berry, R. W., Pomakian, J., Oh, H. S., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.019 · Cited by 147 · see citing works

Neuroprotective strategies against calpain-mediated neurodegeneration

Yıldız, A., Korulu, Ş., & Karabay, A. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s78226 · Cited by 67 · see citing works

The inhibition of LSD1 via sequestration contributes to tau-mediated neurodegenerationPreprint

Engstrom, A. K., Walker, A. C., Moudgal, R. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/745133

Specific Calpain Inhibition by Calpastatin Prevents Tauopathy and Neurodegeneration and Restores Normal Lifespan in Tau P301L Mice

Rao, M. V., McBrayer, M. K., Campbell, J., Kumar, A., Hashim, A. T., Sershen, H. W., Stavrides, P. H., Ohno, M., Hutton, M., & Nixon, R. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1132-14.2014 · Cited by 99 · see citing works